Molecular cloning and functional characterisation of duck (Anas platyrhynchos) tumour necrosis factor receptor-associated factor 3

References

• Amery-Gale, J., C. A. Hartley, P. K. Vaz, M. S. Marenda, J. Owens, P. A. Eden, and J. M. Devlin. 2018. “Avian Viral Surveillance in Victoria, Australia, and Detection of Two Novel Avian Herpesviruses.” PloS One 13 (3): e0194457. doi:10.1371/journal.pone.0194457.
   PubMed Web of Science ®Google Scholar
• Arch, R. H., R. W. Gedrich, and C. B. Thompson. 1998. “Tumor Necrosis Factor Receptor-Associated Factors (Trafs)–A Family of Adapter Proteins that Regulates Life and Death.” Genes & Development 12 (18): 2821–2830. doi:10.1101/gad.12.18.2821.
   PubMed Web of Science ®Google Scholar
• Cai, J., H. Xia, Y. Huang, J. Tang, J. Jian, Z. Wu, and Y. Lu. 2015. “Identification and Characterization of Tumor Necrosis Factor Receptor (Tnfr)-Associated Factor 3 from Humphead Snapper, Lutjanus Sanguineus.” Fish & Shellfish Immunology 46 (2): 243–251. doi:10.1016/j.fsi.2015.06.021.
   PubMed Web of Science ®Google Scholar
• Chiba, Y., T. Matsumiya, T. Satoh, R. Hayakari, K. Furudate, F. Xing, H. Yoshida, et al. 2015. “Retinoic Acid-Inducible gene-I-like Receptor (Rlr)-Mediated Antiviral Innate Immune Responses in the Lower Respiratory Tract: Roles of TRAF3 and TRAF5.” Biochemical and Biophysical Research Communications 467 (2): 191–196. doi:10.1016/j.bbrc.2015.10.010.
   PubMed Web of Science ®Google Scholar
• Chung, J. Y., Y. C. Park, Y. Hong, and W. Hao. 2002a. “All TRAFs are Not Created Equal: Common and Distinct Molecular Mechanisms of TRAF-mediated Signal Transduction.” Commentary 115 (4): 679–688.
   Google Scholar
• Chung, J. Y., Y. C. Park, H. Ye, and H. Wu. 2002b. “All TRAFs are Not Created Equal: Common and Distinct Molecular Mechanisms of TRAF-mediated Signal Transduction.” Journal of Cell Science 115 (Pt 4): 679–688.
   PubMed Web of Science ®Google Scholar
• Courtois, G., and M. O. Fauvarque. 2018. “The Many Roles of Ubiquitin in NF-kappaB Signaling.” Biomedicines 6 (2): E43. doi:10.3390/biomedicines6020043.
   PubMed Web of Science ®Google Scholar
• Devergne, O., E. Hatzivassiliou, K. M. Izumi, K. M. Kaye, M. F. Kleijnen, E. Kieff, and G. Mosialos. 1996. “Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr Virus LMP1 Domain Important for B-Lymphocyte Transformation: Role in NF-kappaB Activation.” Molecular and Cellular Biology 16 (12): 7098–7108. doi:10.1128/MCB.16.12.7098.
   PubMed Web of Science ®Google Scholar
• Frank-Bertoncelj, M., D. S. Pisetsky, C. Kolling, B. A. Michel, R. E. Gay, A. Jungel, and S. Gay. 2018. “TLR3 Ligand Poly(I:C) Exerts Distinct Actions in Synovial Fibroblasts When Delivered by Extracellular Vesicles.” Frontiers in Immunology 9: 28. doi:10.3389/fimmu.2018.00028.
   PubMed Web of Science ®Google Scholar
• Grano, F. G., S. Silva, J. E. Dos, G. D. Melo, M. S. de Souza, V. M. F. Lima, and G. F. Machado. 2018. “Toll-Like Receptors and Cytokines in the Brain and in Spleen of Dogs with Visceral Leishmaniosis.” Veterinary Parasitology 253: 30–38. doi:10.1016/j.vetpar.2018.02.030.
   PubMed Web of Science ®Google Scholar
• Guven-Maiorov, E., O. Keskin, A. Gursoy, C. VanWaes, Z. Chen, C. J. Tsai, and R. Nussinov. 2016. “TRAF3 Signaling: Competitive Binding and Evolvability of Adaptive Viral Molecular Mimicry.” Biochimica Et Biophysica Acta 1860 (11 Pt B): 2646–2655. doi:10.1016/j.bbagen.2016.05.021.
   PubMed Web of Science ®Google Scholar
• He, J. Q., S. K. Saha, J. R. Kang, B. Zarnegar, and G. Cheng. 2007. “Specificity of TRAF3 in Its Negative Regulation of the Noncanonical NF-kappa B Pathway.” The Journal of Biological Chemistry 282 (6): 3688–3694. doi:10.1074/jbc.M610271200.
   PubMed Web of Science ®Google Scholar
• Huai, W., H. Song, Z. Yu, W. Wang, L. Han, T. Sakamoto, M. Seiki, L. Zhang, Q. Zhang, and W. Zhao. 2016. “Mint3 Potentiates TLR3/4- and RIG-I-induced IFN-beta Expression and Antiviral Immune Responses.” Proceedings of the National Academy of Sciences of the United States of America 113 (42): 11925–11930. doi:10.1073/pnas.1601556113.
   PubMed Web of Science ®Google Scholar
• Hung, J. H., and Z. Weng. 2016. “Sequence Alignment and Homology Search.” Cold Spring Harbor Protocols 2016 (11): pdb top093070. doi:10.1101/pdb.top093070.
   Google Scholar
• Ishida, T., S. Si Mizushima, N. K. Azuma, T. Tojo, K. Suzuki, S. Aizawa, T. Watanabe, et al. 1996b. “Identification of TRAF6, a Novel Tumor Necrosis Factor Receptor-Associated Factor Protein that Mediates Signaling from an Amino-Terminal Domain of the CD40 Cytoplasmic Region.” The Journal of Biological Chemistry 271 (46): 28745–28748. doi:10.1074/jbc.271.46.28745.
   PubMed Web of Science ®Google Scholar
• Ishida, T. K., T. Tojo, T. Aoki, N. Kobayashi, T. Ohishi, T. Watanabe, T. Yamamoto, and J. Inoue. 1996a. “TRAF5, a Novel Tumor Necrosis Factor Receptor-Associated Factor Family Protein, Mediates CD40 Signaling.” Proceedings of the National Academy of Sciences of the United States of America 93 (18): 9437–9442. doi:10.1073/pnas.93.18.9437.
   PubMed Web of Science ®Google Scholar
• Jin, J., H. Hu, H. S. Li, J. Yu, Y. Xiao, G. C. Brittain, Q. Zou, et al. 2014. “Noncanonical NF-kappaB Pathway Controls the Production of Type I Interferons in Antiviral Innate Immunity.” Immunity 40 (3): 342–354. doi:10.1016/j.immuni.2014.02.006.
   PubMed Web of Science ®Google Scholar
• Kim, J. K., N. J. Negovetich, H. L. Forrest, and R. G. Webster. 2009. “Ducks: The “Trojan Horses” of H5N1 Influenza.” Influenza Other Respir Viruses 3 (4): 121–128. doi:10.1111/j.1750-2659.2009.00084.x.
   PubMed Web of Science ®Google Scholar
• Liu, G., X. Zhai, H. Zhou, X. Yang, N. Zhang, G. Tai, and W. Ni. 2018. “The Combination of Maltose-Binding Protein and BCG-induced Th1 Activation Is Involved in TLR2/9-mediated Upregulation of MyD88-TRAF6 and TLR4-mediated Downregulation of TRIF-TRAF3.” Cellular Immunology 325: 56–63. doi:10.1016/j.cellimm.2018.02.006.
   PubMed Web of Science ®Google Scholar
• Livak, K. J., and T. D. Schmittgen. 2001. “Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2(-Delta Delta C(T)) Method.” Methods 25 (4): 402–408. doi:10.1006/meth.2001.1262.
   PubMed Web of Science ®Google Scholar
• May, M. J., and S. Ghosh. 1997. “Rel/NF-Kappa B and I Kappa B Proteins: An Overview.” Seminars in Cancer Biology 8 (2): 63–73. doi:10.1006/scbi.1997.0057.
   PubMed Web of Science ®Google Scholar
• Mosialos, G., M. Birkenbach, R. Yalamanchili, T. VanArsdale, C. Ware, and E. Kieff. 1995. “The Epstein-Barr Virus Transforming Protein LMP1 Engages Signaling Proteins for the Tumor Necrosis Factor Receptor Family.” Cell 80 (3): 389–399. doi:10.1016/0092-8674(95)90489-1.
   PubMed Web of Science ®Google Scholar
• Oganesyan, G., S. K. Saha, B. Guo, J. Q. He, A. Shahangian, B. Zarnegar, A. Perry, and G. Cheng. 2006. “Critical Role of TRAF3 in the Toll-Like Receptor-Dependent and -Independent Antiviral Response.” Nature 439 (7073): 208–211. doi:10.1038/nature04374.
   PubMed Web of Science ®Google Scholar
• Perkins, D. J., and S. N. Vogel. 2015. “Space and Time: New Considerations about the Relationship between Toll-Like Receptors (Tlrs) and Type I Interferons (Ifns).” Cytokine 74 (2): 171–174. doi:10.1016/j.cyto.2015.03.001.
   PubMed Web of Science ®Google Scholar
• Regnier, C. H., C. Tomasetto, C. Moog-Lutz, M. P. Chenard, C. Wendling, P. Basset, and M. C. Rio. 1995. “Presence of a New Conserved Domain in CART1, a Novel Member of the Tumor Necrosis Factor Receptor-Associated Protein Family, Which Is Expressed in Breast Carcinoma.” The Journal of Biological Chemistry 270 (43): 25715–25721. doi:10.1074/jbc.270.43.25715.
   PubMed Web of Science ®Google Scholar
• Sachan, S., S. Ramakrishnan, A. Annamalai, B. K. Sharma, H. Malik, B. C. Saravanan, L. Jain, M. Saxena, A. Kumar, and N. Krishnaswamy. 2015. “Adjuvant Potential of Resiquimod with Inactivated Newcastle Disease Vaccine and Its Mechanism of Action in Chicken.” Vaccine 33 (36): 4526–4532. doi:10.1016/j.vaccine.2015.07.016.
   PubMed Web of Science ®Google Scholar
• Saha, S. K., and G. Cheng. 2006. “TRAF3: A New Regulator of Type I Interferons.” Cell Cycle 5 (8): 804–807. doi:10.4161/cc.5.8.2637.
   PubMed Web of Science ®Google Scholar
• Saha, S. K., E. M. Pietras, J. Q. He, J. R. Kang, S. Y. Liu, G. Oganesyan, A. Shahangian, et al. 2006. “Regulation of Antiviral Responses by a Direct and Specific Interaction between TRAF3 and Cardif.” The EMBO Journal 25 (14): 3257–3263. doi:10.1038/sj.emboj.7601220.
   PubMed Web of Science ®Google Scholar
• Sauder, D. N., M. H. Smith, T. Senta-McMillian, I. Soria, and T. C. Meng. 2003. “Randomized, Single-Blind, Placebo-Controlled Study of Topical Application of the Immune Response Modulator Resiquimod in Healthy Adults.” Antimicrobial Agents and Chemotherapy 47 (12): 3846–3852. doi:10.1128/AAC.47.12.3846-3852.2003.
   PubMed Web of Science ®Google Scholar
• Su, X., S. Li, M. Meng, W. Qian, W. Xie, D. Chen, Z. Zhai, and H. B. Shu. 2006. “TNF Receptor-Associated Factor-1 (TRAF1) Negatively Regulates Toll/IL-1 Receptor Domain-Containing Adaptor Inducing IFN-beta (Trif)-Mediated Signaling.” European Journal of Immunology 36 (1): 199–206. doi:10.1002/eji.200535415.
   PubMed Web of Science ®Google Scholar
• Sun, L., C. Hu, and X. Zhang. 2017. “TRAF3 Delays Cyst Formation Induced by NF-kappaB Signaling.” IUBMB Life 69 (3): 170–178. doi:10.1002/iub.1601.
   PubMed Web of Science ®Google Scholar
• Weeratna, R. D., S. R. Makinen, M. J. McCluskie, and H. L. Davis. 2005. “TLR Agonists as Vaccine Adjuvants: Comparison of CpG ODN and Resiquimod (R-848).” Vaccine 23 (45): 5263–5270. doi:10.1016/j.vaccine.2005.06.024.
   PubMed Web of Science ®Google Scholar
• Wei, X., W. Qian, S. Sizhu, L. Yongtao, K. Guo, M. Jin, and H. Zhou. 2018. “Negative Regulation of Interferon-β Production by Alternative Splicing of Tumor Necrosis Factor Receptor-Associated Factor 3 in Ducks.” Frontiers in Immunology 9: 409. doi:10.3389/fimmu.2018.00409.
   PubMed Web of Science ®Google Scholar
• Xie, P. 2013. “TRAF Molecules in Cell Signaling and in Human Diseases.” Journal of Molecular Signaling 8 (1): 7. doi:10.1186/1750-2187-8-7.
   PubMedGoogle Scholar
• Yang, H. L., Z. Q. Feng, S. Q. Zeng, S. M. Li, Q. Zhu, and Y. P. Liu. 2015. “Molecular Cloning and Expression Analysis of TRAF3 in Chicken.” Genetics and Molecular Research : GMR 14 (2): 4408–4419. doi:10.4238/2015.April.30.14.
   PubMed Web of Science ®Google Scholar
• Yang, L., Y. Chang, Y. Wang, J. Wei, C. Ge, and J. Song. 2016. “Identification and Functional Characterization of TNF Receptor Associated Factor 3 in the Sea Cucumber Apostichopus Japonicus.” Developmental and Comparative Immunology 59: 128–135. doi:10.1016/j.dci.2016.01.021.
   PubMed Web of Science ®Google Scholar
• Zhou, Y., X. Kang, D. Xiong, S. Zhu, H. Zheng, Y. Xu, Y. Guo, Z. Pan, and X. Jiao. 2017a. “Molecular and Functional Characterization of Pigeon (Columba Livia) Tumor Necrosis Factor Receptor-Associated Factor 3.” Developmental and Comparative Immunology 69: 51–59. doi:10.1016/j.dci.2016.12.005.
   PubMed Web of Science ®Google Scholar
• Zhou, Z., C. Zeng, L. Nie, S. Huang, C. Guo, D. Xiao, Y. Han, et al. 2017b. “The Effects of TLR3, TRIF and TRAF3 SNPs and Interactions with Environmental Factors on Type 2 Diabetes Mellitus and Vascular Complications in a Han Chinese Population.” Gene 626: 41–47. doi:10.1016/j.gene.2017.05.011.
   PubMed Web of Science ®Google Scholar